Filtered By:
Infectious Disease: Hepatitis B
Therapy: Stem Cell Therapy
This page shows you your search results in order of date.
Order by Relevance | Date
Total 110 results found since Jan 2013.
Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era
World J Gastroenterol. 2023 Sep 7;29(33):4942-4961. doi: 10.3748/wjg.v29.i33.4942.ABSTRACTHepatitis due to hepatitis B virus (HBV) reactivation can be serious and potentially fatal, but is preventable. HBV reactivation is most commonly reported in patients receiving chemotherapy, especially rituximab-containing therapy for hematological malignancies and those receiving stem cell transplantation. Patients with inactive and even resolved HBV infection still have persistence of HBV genomes in the liver. The expression of these silent genomes is controlled by the immune system. Suppression or ablation of immune cells, most imp...
Source: World Journal of Gastroenterology : WJG - September 21, 2023 Category: Gastroenterology Authors: Joyce Wing Yan Mak Alvin Wing Hin Law Kimmy Wan Tung Law Rita Ho Carmen Ka Man Cheung Man Fai Law Source Type: research
Comprehensive Analysis of m7G-Related Genes and Chronic Hepatitis B: Diagnostic Markers, Immune Microenvironment Regulation, Disease Progression
In conclusion, m7G-related genes can not only serve as diagnostic markers of CHB, but also participate in the regulation of immune microenvironment and play an important role in the progression of CHB.PMID:37206976 | PMC:PMC10191754 | DOI:10.1155/2023/9471520
Source: Cell Research - May 19, 2023 Category: Cytology Authors: Rongzheng Zhang Yan Xia Jianming Dong Xiaomei Ju Kun Zhou Xinyang Cao Jiaqi Li Jiaqiu Ru Mengrui Guo Shuyun Zhang Source Type: research
Mesenchymal Stem Cell Transplantation for hepatitis B virus-related acute-on-chronic liver failure:A systematic review and meta-analysis
Curr Stem Cell Res Ther. 2022 Dec 14. doi: 10.2174/1574888X18666221214123844. Online ahead of print.NO ABSTRACTPMID:36518036 | DOI:10.2174/1574888X18666221214123844
Source: Cell Research - December 15, 2022 Category: Cytology Authors: Fang Cheng Zhong Huang Wei Wei Zhi Li Source Type: research
Oncolytic viruses as emerging therapy against cancers including Oncovirus-induced cancers
This study mainly focused on targeting cell proliferation and death pathways in human tumor-inducing viruses by developing innovative therapies for cancer patients based on the natural oncolytic properties of reovirus. To kill tumor cells efficiently and reduce the chance of recurrence both the direct ability of reovirus infection to lyse the tumor cells and the stimulation of a potent host immune response are applied. Hence, bioengineered stem cells can be used as smart carriers to improve the efficacy of oncolytic reovirus and safety profiles.PMID:36435236 | DOI:10.1016/j.ejphar.2022.175393
Source: European Journal of Pharmacology - November 26, 2022 Category: Drugs & Pharmacology Authors: Seyed-Mahmood Seyed-Khorrami Hoorieh Soleimanjahi Marek J Łos Keivan Zandi Reza Zolfaghari Emameh Source Type: research
SOGC Guideline Retirement Notice No. 2
Conclusion [J Obstet Gynaecol Can 35 (2013) S42-S43] Chapter 10 Case Studies [J Obstet Gynaecol Can 35 (2013) S44-S47] Appendix 1. Apology for the Forced Relocation of Inukjuak and Pond Inlet Families [J Obstet Gynaecol Can 35 (2013) S48] Appendix 2. Apology for the Residential School System [J Obstet Gynaecol Can 35 (2013) S49] Appendix 3. Avoiding Re-Traumatization of Sexual Abuse/Assault Victims During the Birthing Process [J Obstet Gynaecol Can 35 (2013) S50].PMID:36241341 | DOI:10.1016/j.jogc.2022.08.012
Source: Journal of Obstetrics and Gynaecology Canada : JOGC - October 14, 2022 Category: OBGYN Source Type: research
